Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-55 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-55 |
filingDate |
2019-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65ffefe2bb0532914c9d45f2a1d69ebd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f49797ce74d2791464ff3695ec2f42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a3fd4693a4171de604356e27d3e7a73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fdd0e55fbe95dc1f7cd781de2f5c974 |
publicationDate |
2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3901167-A1 |
titleOfInvention |
Novel immunosuppressive interleukin 2 |
abstract |
The present invention relates to an interleukin-2 analogue, which has altered binding affinity for interleukin-2 alpha receptor and interleukin-2 beta receptor, compared to the wild type. |
priorityDate |
2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |